No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Induction chemotherapy may improve survival in patients with esophageal adenocarcinoma

byTeddy Guo

November 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response

RelatedReports

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

Quick Take: Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening

AI Roundup

Birth cohort effects observed for increased appendiceal adenocarcinoma incidence

June 9, 2025

Incidence of esophageal cancer subtypes vary drastically globally and by gender

Chronic Disease

Active Surveillance vs Standard Surgery Post-Neoadjuvant Chemoradiotherapy for Esophageal Cancer

March 24, 2025

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

7-day antibiotic therapy is noninferior to 14-day therapy in afebrile men with urinary tract infection

Sleep duration inversely related to childhood type 2 diabetes risk makers

Association between BMI and diabetes risk among low-middle income countries varies considerably by geographical region

Government-funded initiatives provide important supports to low-income HIV patients

Targeted screening not superior to nontargeted screening for human immunodeficiency virus in the emergency department

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports